Dr Joesph Gabriele

Dr. Joseph Gabriele, Ph.D. Chief Science Officer Joseph Gabriele, Ph.D., is a molecular pharmacologist specializing in signal transduction within the central nervous system; he works in the areas of molecular pharmacology, transdermal delivery, and formulation chemistry with pharmaceutical, natural molecules. Dr. Gabriele lectures on these topics across North America and Europe. Dr. Gabriele received his B.Sc. degree from the University of Toronto, his M.Sc. and Ph.D. degrees from McMaster University, and Postdoctoral training at Queens University A visionary and a relentless innovator, Dr. Gabriele led the development of a transdermal delivery platform, delivra^TM, that can be tailored to carry drugs across the skin and into the skin dermis, circulatory system or muscles. As a co-founder of Delivra Corp in 2007, Joseph along with his team have developed a transdermal platform that can shuttle, small biologics to large peptides across the skin layers in a targeted specific manner. As an Industrial partner with the National Research Council of Canada, Dr. Gabriele’s group conducts research in an analytical/molecular biology laboratory located in Prince Edward Island, Canada. Dr. Gabriele has received numerous awards throughout his educational career, including a Canadian Institutes of Health Research (CIHR) studentship award in pharmacology, an NSERC Canada Graduate Scholarship, and an Ontario Mental Health Foundation Postdoctoral Fellowship. In 2007, he received the International Congress on Schizophrenia Research “New Investigator Award,” and in 2008, the Hamilton Health Sciences “New Investigator Award.” In 2018, Dr. Gabriele was bestowed the Ernest & Young Entrepreneur of Year in Health Care. Joseph has extensive experience in start companies that commercialize products for Medical Sciences and the Health Care Industry